In vivo effects of two novel alkylating benzodiazepines, irazepine and kenazepine

@article{Williams1981InVE,
  title={In vivo effects of two novel alkylating benzodiazepines, irazepine and kenazepine},
  author={E. F. Williams and K. Rice and M. Mattson and S. Paul and P. Skolnick},
  journal={Pharmacology Biochemistry and Behavior},
  year={1981},
  volume={14},
  pages={487-491}
}
  • E. F. Williams, K. Rice, +2 authors P. Skolnick
  • Published 1981
  • Chemistry, Medicine
  • Pharmacology Biochemistry and Behavior
  • Intracerebroventricular administration of the alkylating benzodiazepines irazepine or kenazepine (20 nmol) resulted in a complete protection against convulsant doses of pentylenetetrazole (PTZ) for at least one hour, and a statistically significant protection for at least two and four hours, respectively. In contrast, administration of the non-alkylating parent benzodiazepine Ro-7/1986 or diazepam (20-60 nmol) resulted in no detectable anticonvulsants effects at fifteen minutes post-injection… CONTINUE READING
    4 Citations

    References

    SHOWING 1-9 OF 9 REFERENCES
    Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors
    • 387
    Statistical Methods
    • 33,804
    Statistical methods